TEVA PHARMACEUTICAL INDUSTRIES LIMITED Business Combination, Consideration Transferred
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Business Combination, Consideration Transferred of $39.27 billion for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-12.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2018-02-12
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED business combination, consideration transferred for fiscal 2016 was $39.27B.
| Period end | Business Combination, Consideration Transferred 12 month |
|---|---|
| 2016-12-31 | $39.27B 10-K · filed 2018-02-12 |